Bausch Health Companies Inc.BHCNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank54
3Y CAGR-45.2%
5Y CAGR-16.1%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-45.2%/yr
vs +34.6%/yr prior
5Y CAGR
-16.1%/yr
Recent deceleration
Acceleration
-79.8pp
Decelerating
Percentile
P54
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 22.45% |
| Q3 2025 | 40.14% |
| Q2 2025 | 36.97% |
| Q1 2025 | -64.89% |
| Q4 2024 | 48.88% |
| Q3 2024 | 6.59% |
| Q2 2024 | 79.50% |
| Q1 2024 | -45.90% |
| Q4 2023 | 38.30% |
| Q3 2023 | 35.65% |
| Q2 2023 | 34.99% |
| Q1 2023 | -64.88% |
| Q4 2022 | 136.39% |
| Q3 2022 | -1459.79% |
| Q2 2022 | 240.66% |
| Q1 2022 | -362.50% |
| Q4 2021 | -95.74% |
| Q3 2021 | 58.15% |
| Q2 2021 | -19.50% |
| Q1 2021 | 12.44% |
| Q4 2020 | 53.91% |
| Q3 2020 | 39.87% |
| Q2 2020 | -20.29% |
| Q1 2020 | -1.87% |
| Q4 2019 | -54.56% |
| Q3 2019 | 51.92% |
| Q2 2019 | -17.92% |
| Q1 2019 | 29.47% |
| Q4 2018 | -38.89% |
| Q3 2018 | 135.14% |
| Q2 2018 | -49.32% |
| Q1 2018 | -24.22% |
| Q4 2017 | 17.96% |
| Q3 2017 | 82.84% |
| Q2 2017 | -71.91% |
| Q1 2017 | 86.15% |
| Q4 2016 | -9.82% |
| Q3 2016 | 26.82% |
| Q2 2016 | -19.71% |
| Q1 2016 | -0.76% |